Investmark Advisory Group’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$559K Sell
1,212
-29
-2% -$14.7K 0.24% 74
2025
Q4
$703K Hold
1,241
0.3% 62
2025
Q3
$555K Hold
1,241
0.24% 70
2025
Q2
$674K Hold
1,241
0.32% 60
2025
Q1
$615K Sell
1,241
-6
-0.5% -$3.32K 0.3% 58
2024
Q4
$651K Hold
1,247
0.32% 55
2024
Q3
$613K Buy
1,247
+15
+1% +$6.98K 0.3% 61
2024
Q2
$548K Hold
1,232
0.29% 63
2024
Q1
$492K Hold
1,232
0.27% 69
2023
Q4
$416K Buy
1,232
+19
+2% +$5.66K 0.24% 75
2023
Q3
$355K Sell
1,213
-2
-0.2% -$625 0.24% 74
2023
Q2
$415K Sell
1,215
-321
-21% -$97.1K 0.28% 66
2023
Q1
$392K Hold
1,536
0.29% 62
2022
Q4
$408K Buy
1,536
+52
+4% +$12.7K 0.3% 65
2022
Q3
$278K Buy
1,484
+242
+19% +$52K 0.25% 69
2022
Q2
$249K Hold
1,242
0.25% 67
2022
Q1
$374K Sell
1,242
-25
-2% -$7.3K 0.39% 49
2021
Q4
$455K Buy
+1,267
New +$436K 0.43% 40

Other funds holding ISRG

Investmark Advisory Group's ISRG Position: Q1 2026 in Review

Investmark Advisory Group reduced its Intuitive Surgical (ISRG) stake by 2.3% in Q1 2026, selling an estimated $14.7K and leaving 1,212 shares worth $559K. The position accounts for 0.24% of the portfolio, ranked #74.

Investmark Advisory Group first reported a position in ISRG in Q4 2021 and has held it in 18 quarters since. The position peaked at $703K in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Investmark Advisory Group held 1,212 shares of Intuitive Surgical worth $559K as of Q1 2026.
  • Investmark Advisory Group sold 29 Intuitive Surgical shares in Q1 2026, an estimated $14.7K.
  • Intuitive Surgical made up 0.24% of Investmark Advisory Group's portfolio in Q1 2026, its #74 holding.
  • Investmark Advisory Group first reported a position in Intuitive Surgical in Q4 2021 and has held it in 18 quarters since.
  • Investmark Advisory Group's Intuitive Surgical position peaked at $703K in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Investmark Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.